WordNet

of or relating to a cavity or chamber in the body (especially one of the upper chambers of the heart)
muscular twitching involving individual muscle fibers acting without coordination
act or process of forming fibrils

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 心房細動：塞栓予防のための抗血栓治療 atrial fibrillation anticoagulant therapy to prevent embolization
2. 心房細動の概要 overview of atrial fibrillation
3. 心房細動の疫学および危険因子 epidemiology of and risk factors for atrial fibrillation
4. 発作性心房細動 paroxysmal atrial fibrillation
5. 心房細動および慢性腎臓病を有する患者における血栓塞栓症リスクのマネージメント management of thromboembolic risk in patients with atrial fibrillation and chronic kidney disease

Apixaban: a new factor xa inhibitor for stroke prevention in patients with nonvalvular atrial fibrillation.

Lam S.SourceFrom the Department of Clinical Pharmacy Practice, College of Pharmacy and Health Sciences, St. John's University, Queens, NY; and Divisions of Geriatric Medicine and Pharmacy, Winthrop University Hospital, Mineola, NY.
Cardiology in review.Cardiol Rev.2013 Jul-Aug;21(4):207-12. doi: 10.1097/CRD.0b013e318293d6e6.
Atrial fibrillation (AF) is an independent risk factor for ischemic stroke occurrence, severity, recurrence, and mortality. Anticoagulation therapy for the prevention of thromboembolism is critical in patients with AF who are at risk of stroke. Warfarin has been an efficacious anticoagulant for this
PMID 23535530

Antithrombotic therapy for patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention: a review.

Krasner A, Halperin JL.SourceThe Cardiovascular Institute, Mount Sinai Medical Center, New York, NY, USA.
Current cardiology reports.Curr Cardiol Rep.2013 Jul;15(7):378. doi: 10.1007/s11886-013-0378-y.
Patients with atrial fibrillation who have risk factors for thromboembolism benefit from chronic oral anticoagulation therapy, and antiplatelet therapy alone is of relatively little benefit for prevention of ischemic stroke and systemic embolism. Patients undergoing percutaneous coronary interventio
PMID 23689944

Edoxaban in Japanese Patients With Nonvalvular Atrial Fibrillation : Not the Same Dose for Everybody

ROLDAN Vanessa,MARIN Francisco,LIP Gregory Y. H.
Circulation journal : official journal of the Japanese Circulation Society 76(8), 1826-1827, 2012-07-25
NAID 10030504159

Right Atrial Anatomical Remodeling Affects Early Outcomes of Nonvalvular Atrial Fibrillation After Radiofrequency Ablation

MOON Jeonggeun,HONG Yoo Jin,SHIM Jaemin,HWANG Hye-Jin,KIM Jong-Youn,PAK Hui-Nam,LEE Moon-Hyoung,JOUNG Boyoung
Circulation journal : official journal of the Japanese Circulation Society 76(4), 860-867, 2012-03-25
… biBackground:/i/b The impact of the right atrial (RA) anatomical remodeling on outcomes of atrial fibrillation (AF) after radiofrequency ablation (RFA) is unclear. … Both RA and left atrial (LA) volumes, measured with multidetector computed tomography, as well as echocardiographic parameters were compared between subjects with early (3 months, n=13) or 1-year (n=19) recurrence after RFA and without recurrence. …
NAID 10030131083